Barclays’s Tevogen Inc TVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-33
Closed -$187 – 5782
2026
Q2
$187 Sell
33
-216
-87% -$1.72K ﹤0.01% 5117
2026
Q1
$1.13K Sell
249
-1,063
-81% -$13K ﹤0.01% 4896
2025
Q4
$21.7K Buy
1,312
+171
+15% +$4.44K ﹤0.01% 4861
2025
Q3
$44.8K Sell
1,141
-231
-17% -$11.4K ﹤0.01% 4792
2025
Q2
$85.7K Buy
1,372
+611
+80% +$34.8K ﹤0.01% 4619
2025
Q1
$41.1K Sell
761
-151
-17% -$9.9K ﹤0.01% 4668
2024
Q4
$47K Buy
912
+257
+39% +$16.7K ﹤0.01% 4777
2024
Q3
$12.1K Buy
655
+505
+337% +$14.8K ﹤0.01% 4955
2024
Q2
$5.44K Buy
+150
New +$9.8K ﹤0.01% 4573
2023
Q1
– Sell
-714
Closed -$369K – 5404
2022
Q4
$369K Sell
714
-3,000
-81% -$1.54M ﹤0.01% 3498
2022
Q3
$1.88M Hold
3,714
– – ﹤0.01% 1792
2022
Q2
$1.86M Hold
3,714
– – ﹤0.01% 1902
2022
Q1
$1.86M Buy
+3,714
New +$1.85M ﹤0.01% 1922

Other funds holding TVGN

Barclays's TVGN Position: Q3 2026 in Review

Barclays sold out of Tevogen Inc (TVGN) in Q3 2026, closing a stake of 33 shares — an estimated $187 sold.

Barclays first reported a position in TVGN in Q1 2022 and held it in 13 quarters. The position peaked at $1.88M in Q3 2022. 15 funds tracked by Wall St. Rank hold TVGN as of Q3 2026.

  • Barclays reported no remaining Tevogen Inc position as of Q3 2026 after selling out during the quarter.
  • Barclays sold 33 Tevogen Inc shares in Q3 2026, an estimated $187.
  • Barclays first reported a position in Tevogen Inc in Q1 2022 and held it in 13 quarters.
  • Barclays's Tevogen Inc position peaked at $1.88M in Q3 2022.
  • 15 funds tracked by Wall St. Rank held Tevogen Inc as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.